Given the drugs impact on reducing appetites and calorie intake, increasing AOM prevalence can shape demand for food, beverages and restaurants, and we anticipate meaningful impact in areas such as packaged food and beverages, restaurants, grocery stores and weight loss programs. While its early days, AOM patients report a 23% reduction in daily meals and 50% reduction in snacks, according to Morgan Stanley
Eating window ends Continue to drink water as desired
1 2 "First generic weight-loss injection approved in Canada", CTV News website , archived from the original on 30 June 2026 1 2 3 "Health Canada approves generic Ozempic from Apotex, country's largest drug maker", The Globe and Mail website , archived from the original on 1 May 2026 "Health Canada approves 2nd generic version of Ozempic and it's Canadian", The Canadian Press website , archived from the original on 15 May 2026 "1st generic semaglutide injection for weight loss approved: Health Canada", CBC News website , archived from the original on 30 June 2026 "Details for: SEVMIA", Drug and Health Product Portal , Health Canada, 29 June 2026, archived from the original on 29 June 2026 "Cheaper, generic versions of Ozempic could come to Canada as early as next year"
Semaglutide's role in weight management extends beyond just appetite suppression
More water means lower concentration and larger injection volumes, but greater measurement accuracy for small doses